TAG
Most prescribed drugs globally; approved for primary and secondary cardiovascular prevention
13 Apr 2026
Approved for type 2 diabetes, heart failure, and chronic kidney disease; off-label longevity and cardiometabolic optimization
13 Apr 2026
Wakefulness promotion with schedule IV controls
13 Apr 2026
FDA-approved OTC topical for hair loss; oral off-label but increasingly prescribed
13 Apr 2026
Antioxidant with cognitive enhancement potential, serotonin syndrome risk critical
13 Apr 2026
Neuroprotective at 5-20mg daily; regulatory ambiguity between pharmaceutical lithium and supplements
13 Apr 2026
Low Dose Naltrexone (LDN)
13 Apr 2026
5-alpha reductase inhibitor: approved for BPH, off-label for androgenetic alopecia
13 Apr 2026
Cabergoline
13 Apr 2026
Alpha-glucosidase inhibitor: approved for type 2 diabetes, longevity potential in animal models
13 Apr 2026
The Standard Treatment for Thyroid Hormone Replacement
13 Apr 2026
Direct T3 or Natural Desiccated Thyroid for Patients Unresponsive to T4 Alone
13 Apr 2026
Bug report, content request, or general comment — we read everything.